---  
layout: startup_page  
title: "ATB Therapeutics"  
id: "atbtherapeutics.com"  
permalink: "/atbtherapeuticsatbtherapeutics.com11182024/"  
website: "https://www.atbtherapeutics.com/"  
funding_round: "Series A"  
funding_amount: "€54M"  
investors: "EQT Life Sciences, MRL Ventures Fund, V-Bio, VIVES Partners, SFPIM, Wallonie Entreprendre, Sambrinvest, existing investors"  
about: "ATB Therapeutics develops first-in-class biologics incorporating novel cell-killing mechanisms within targeted antibodies. Their proprietary ATBioFarm platform enables scalable, single-step production of these advanced therapeutics, offering potential advancements in oncology and immunology. This innovative approach addresses critical challenges in selecting ADC drug candidates and opens avenues for new mechanisms of action."  
markets: "Oncology, Immunology, Biotechnology, Health Care, Therapeutics"  
hq: "Aye, Luxembourg, Belgium"  
founded_year: "2018"  
linkedin: "https://be.linkedin.com/company/atbtherapeutics"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/atb-therapeutics"  
pitchbook: ""  

date_display: "18-Nov-2024"  
date: "2024-11-18"

# SEO Optimization  
meta_title: "ATB Therapeutics - Series A Funding (€54M)"  
meta_description: "ATB Therapeutics, ATB Therapeutics develops first-in-class biologics incorporating novel cell-killing mechanisms within targeted antibodies. Their proprietary ATBioFarm..."  
meta_keywords: "ATB Therapeutics, Oncology, Immunology, Biotechnology, Health Care, Therapeutics, Series A funding"  
canonical_url: "https://startup.projectstartups.com/atbtherapeuticsatbtherapeutics.com11182024/"  
---